• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ADA diabetes roundup: Mayo Clinic answers the call for progress toward an artificial pancreas

ADA diabetes roundup: Mayo Clinic answers the call for progress toward an artificial pancreas

June 27, 2011 By MassDevice staff

ADA

Plenty more news streamed out of the conference of the American Diabetes Assn. over the weekend, including progress toward an artificial pancreas, data on young diabetics at risk for heart disease and mobile apps for prevention and management of diabetes.

More than 13,500 people gathered in San Diego at the 71st annual scientific conference of the ADA to lead the fight against diabetes, a disease that affects more than 26 million children and adults in the U.S., according to the ADA.

Already diabetes contributes to the deaths of more than 231,000 Americans each year, more than breast cancer and AIDS combined. By 2020, the ADA estimates that more than half of adult Americans will have diabetes or pre-diabetes.

The ADA estimates that the total cost of diagnosed diabetes in the U.S. tops $174 billion. Added costs associated with gestational diabetes, pre-diabetes and undiagnosed diabetes bring the total up to an estimated $218 billion.

  • Mayo Clinic unveils work on artificial pancreas

    Following the FDA’s release of draft guidance aimed at advancing the approval of artificial pancreas systems, researchers at the Mayo Clinic in Rochester, Minn., to relieve diabetic patients of the need for frequent finger-pricks and insulin dosing.

    Artificial pancreas systems combine a continuous glucose monitor, an insulin infusion pump and a glucose meter. The artificial pancreas monitors glucose levels and automatically adjusts insulin doses, but still requires that patients keep an eye on their blood sugar and supplement themselves with an insulin injection when necessary.

    Mayo researchers Dr. Yogish Kudva and Dr. Ananda Basu studied how the mundane movements of everyday life affect blood sugar levels. Among the newest findings is that even basic physical activity after meals has a profound impact on blood sugar levels for people with type 1 diabetes.

    Clinical trials are expected to begin in November, according to the release.

    In the video, Dr. Kudva explains more.

    Read more


  • Young people with type 1 diabetes at risk for heart disease
    Adolescents with type 1 diabetes have thicker and stiffer carotid arteries, also known as atherosclerosis, according to new research from a collaboration between the Colorado School of Public Health and the Cincinnati Children’s Hospital Medical Center. Atherosclerosis is a risk factor for heart attack and stroke in adults.
    Read more
  • Mobile health apps inspire ADA diabetes pilots
    The American Diabetes Assn. and the Centers for Disease Control & Prevention announced a collaboration with the Office of the National Coordinator of Health Information Technology to drive mobile health programs to help individuals better manage and prevent diabetes.
    Read more
  • Medtronic touts clinical evidence of its sensor-augmented insulin pump
    Medtronic Inc. (NYSE:MDT) touted results from trials of its sensor-augmented insulin pump, the only FDA-cleared pump of its kind.

    "Extensive clinical research has proven that our advancements in insulin delivery and continuous glucose monitoring technologies have improved outcomes for people with diabetes," said Dr. Francine Kaufman, chief medical officer and VP of global medical, clinical & health affairs at Medtronic.
    Read more

  • Life expectancy improving for those with type 1 diabetes
    People diagnosed with type 1 diabetes between 1965 and 1980 lived an average of 15 years longer than those diagnosed between 1950 and 1964, according to researchers at the University of Pittsburgh Schools of the Health Sciences.
    Read more
  • Dermagraft treatment for diabetic foot ulcers proves cost-effective
    Advanced BioHealing Inc., which recently sold to Shire Plc. (NASDAQ:SHPGY )  for $750 million, touted economic models that demonstrate use of Dermagraft treatment used alongside conventional care resulted in significant therapeutic and cost benefits compared to conventional care alone.
    Read more

Filed Under: News Well, Research & Development Tagged With: Advanced BioHealing Inc., Mayo Clinic, Shire Plc.

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy